Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Matteo Bassetti and Francesco De Rosa.
Connection Strength

1.915
  1. Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect Dis Ther. 2021 Dec; 10(4):1837-1885.
    View in: PubMed
    Score: 0.240
  2. Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med. 2021 08; 15(8):985-992.
    View in: PubMed
    Score: 0.237
  3. Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021 Feb 03; 10(4).
    View in: PubMed
    Score: 0.232
  4. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020 Jul; 26(7):880-894.
    View in: PubMed
    Score: 0.220
  5. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr; 62(4):310-319.
    View in: PubMed
    Score: 0.201
  6. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect. 2018 Feb; 24(2):133-144.
    View in: PubMed
    Score: 0.183
  7. Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017 May; 3(5):e156.
    View in: PubMed
    Score: 0.178
  8. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med. 2017 Apr; 43(4):509-518.
    View in: PubMed
    Score: 0.177
  9. The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
    View in: PubMed
    Score: 0.058
  10. Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
    View in: PubMed
    Score: 0.052
  11. Ceftolozane/tazobactam: place in therapy. Expert Rev Anti Infect Ther. 2018 04; 16(4):307-320.
    View in: PubMed
    Score: 0.047
  12. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
    View in: PubMed
    Score: 0.046
  13. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother. 2017 Aug; 29(4):197-214.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.